InsidersTradesSigma
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Explore the detailed record of transactions filed by HARTOUNIAN HARTOUN. Director active across 1 company, notably Brainstorm Cell Therapeutics INC.. Aggregated, 2 reports have been recorded. History available since 24 June 2024. The latest transaction was filed on 1 January 2025 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
2 of 2 declarations